• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分离并鉴定一种类人源抗体片段(scFv),该片段可在体外和体内使 VEEV 失活。

Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo.

机构信息

Technische Universität Braunschweig, Institut für Biochemie und Biotechnologie, Braunschweig, Germany.

出版信息

PLoS One. 2012;7(5):e37242. doi: 10.1371/journal.pone.0037242. Epub 2012 May 30.

DOI:10.1371/journal.pone.0037242
PMID:22666347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3364240/
Abstract

Venezuelan equine encephalitis virus (VEEV) belongs to the Alphavirus genus and several species of this family are pathogenic to humans. The viruses are classified as potential agents of biological warfare and terrorism and sensitive detection as well as effective prophylaxis and antiviral therapies are required.In this work, we describe the isolation of the anti-VEEV single chain Fragment variable (scFv), ToR67-3B4, from a non-human primate (NHP) antibody gene library. We report its recloning into the bivalent scFv-Fc format and further immunological and biochemical characterisation.The scFv-Fc ToR67-3B4 recognised viable as well as formalin and ß-propionolactone (ß-Pl) inactivated virus particles and could be applied for immunoblot analysis of VEEV proteins and immuno-histochemistry of VEEV infected cells. It detected specifically the viral E1 envelope protein of VEEV but did not react with reduced viral glycoprotein preparations suggesting that recognition depends upon conformational epitopes. The recombinant antibody was able to detect multiple VEEV subtypes and displayed only marginal cross-reactivity to other Alphavirus species except for EEEV. In addition, the scFv-Fc fusion described here might be of therapeutic use since it successfully inactivated VEEV in a murine disease model. When the recombinant antibody was administered 6 hours post challenge, 80% to 100% of mice survived lethal VEEV IA/B or IE infection. Forty to sixty percent of mice survived when scFv-Fc ToR67-3B4 was applied 6 hours post challenge with VEEV subtypes II and former IIIA. In combination with E2-neutralising antibodies the NHP antibody isolated here could significantly improve passive protection as well as generic therapy of VEE.

摘要

委内瑞拉马脑炎病毒(VEEV)属于甲病毒属,该属的几种病毒对人类具有致病性。这些病毒被归类为生物战剂和恐怖主义的潜在制剂,因此需要进行敏感检测以及有效的预防和抗病毒治疗。在这项工作中,我们从非人类灵长类动物(NHP)抗体基因文库中分离出抗 VEEV 的单链片段可变区(scFv),ToR67-3B4。我们报告了它在双价 scFv-Fc 格式中的重新克隆,并进一步对其进行了免疫和生化特性分析。scFv-Fc ToR67-3B4 可识别活病毒以及福尔马林和β-丙内酯(β-Pl)灭活的病毒颗粒,可用于 VEEV 蛋白的免疫印迹分析和 VEEV 感染细胞的免疫组织化学分析。它特异性地检测到 VEEV 的 E1 包膜蛋白,但与还原的病毒糖蛋白制剂没有反应,这表明识别取决于构象表位。该重组抗体能够检测到多种 VEEV 亚型,除了EEEV 之外,与其他甲病毒属的物种仅有轻微的交叉反应性。此外,由于该 scFv-Fc 融合体成功地在小鼠疾病模型中灭活了 VEEV,因此它可能具有治疗用途。当在挑战后 6 小时给予重组抗体时,80%至 100%的小鼠能够从致死性 VEEV IA/B 或 IE 感染中存活。当在 VEEV 亚型 II 和前 IIIA 挑战后 6 小时应用 scFv-Fc ToR67-3B4 时,40%至 60%的小鼠存活。与 E2 中和抗体联合使用,该 NHP 抗体可以显著提高 VEE 的被动保护和通用治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/a7d6ab9a8d2b/pone.0037242.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/e2ff4795cdf3/pone.0037242.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/3f3e1f452660/pone.0037242.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/141c715c93b0/pone.0037242.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/6b934f961392/pone.0037242.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/a7d6ab9a8d2b/pone.0037242.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/e2ff4795cdf3/pone.0037242.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/3f3e1f452660/pone.0037242.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/141c715c93b0/pone.0037242.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/6b934f961392/pone.0037242.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26e/3364240/a7d6ab9a8d2b/pone.0037242.g005.jpg

相似文献

1
Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo.分离并鉴定一种类人源抗体片段(scFv),该片段可在体外和体内使 VEEV 失活。
PLoS One. 2012;7(5):e37242. doi: 10.1371/journal.pone.0037242. Epub 2012 May 30.
2
Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV).利用抗体噬菌体展示技术开发用于检测和诊断委内瑞拉马脑炎病毒(VEEV)的人源抗体片段。
BMC Biotechnol. 2008 Sep 2;8:66. doi: 10.1186/1472-6750-8-66.
3
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.重组伊斯法罕病毒和水疱性口炎病毒疫苗载体可提供针对致死性甲病毒攻击的持久、多价、单剂量保护。
J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.01729-16. Print 2017 Apr 15.
4
The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.首张甲病毒 E1 和 E2 蛋白的人源表位图谱揭示了具有显著病毒中和活性的新 E2 表位。
PLoS Negl Trop Dis. 2010 Jul 13;4(7):e739. doi: 10.1371/journal.pntd.0000739.
5
Human-like antibodies neutralizing Western equine encephalitis virus.可中和西部马脑炎病毒的类人抗体。
MAbs. 2014 May-Jun;6(3):718-27. doi: 10.4161/mabs.28170. Epub 2014 Feb 11.
6
Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.工程化间充质细胞可增强对致命性委内瑞拉马脑炎病毒暴露的被动免疫保护。
Stem Cells Transl Med. 2016 Aug;5(8):1026-35. doi: 10.5966/sctm.2015-0341. Epub 2016 Jun 22.
7
Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.基于新型昆虫特异性埃拉特病毒的嵌合疫苗候选物可提供持久的单剂量和多价保护,抵御致死性甲病毒攻击。
J Virol. 2018 Jan 30;92(4). doi: 10.1128/JVI.01274-17. Print 2018 Feb 15.
8
Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains.研发一种新型单克隆抗体,可与多种委内瑞拉马脑炎病毒株发生反应。
Virol J. 2009 Nov 19;6:206. doi: 10.1186/1743-422X-6-206.
9
Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.委内瑞拉马脑炎病毒和西部马脑炎病毒E1脂质体抗原核酸复合物可保护小鼠免受多种甲病毒的致死性攻击。
Virology. 2016 Dec;499:30-39. doi: 10.1016/j.virol.2016.08.023. Epub 2016 Sep 12.
10
Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.来自人源染色体奶牛的抗体制剂对委内瑞拉马脑炎病毒具有预防和治疗功效。
J Virol. 2017 Jun 26;91(14). doi: 10.1128/JVI.00226-17. Print 2017 Jul 15.

引用本文的文献

1
Requirement for Fc effector function is overcome by binding potency for broadly reactive anti-alphavirus antibodies.对广泛反应性抗甲病毒抗体的结合效力克服了对Fc效应子功能的需求。
bioRxiv. 2024 Nov 3:2024.11.03.619087. doi: 10.1101/2024.11.03.619087.
2
Syrian Hamsters Model Does Not Reflect Human-like Disease after Aerosol Exposure to Encephalitic Alphaviruses.叙利亚仓鼠模型在气溶胶暴露于脑炎甲病毒后不能反映类人疾病。
Methods Protoc. 2024 May 15;7(3):42. doi: 10.3390/mps7030042.
3
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function.

本文引用的文献

1
Microbial inactivation for safe and rapid diagnostics of infectious samples.微生物灭活以安全快速诊断感染性样本。
Appl Environ Microbiol. 2011 Oct;77(20):7289-95. doi: 10.1128/AEM.05553-11. Epub 2011 Aug 19.
2
Differential accumulation of genetic and phenotypic changes in Venezuelan equine encephalitis virus and Japanese encephalitis virus following passage in vitro and in vivo.委内瑞拉马脑炎病毒和日本脑炎病毒在体外和体内传代后遗传和表型变化的差异积累。
Virology. 2011 Jun 20;415(1):20-9. doi: 10.1016/j.virol.2011.03.030. Epub 2011 Apr 19.
3
Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection.
高效抗委内瑞拉马脑炎病毒抗体的治疗效果取决于 Fc 效应功能。
MAbs. 2024 Jan-Dec;16(1):2297451. doi: 10.1080/19420862.2023.2297451. Epub 2024 Jan 3.
4
Defining the Cynomolgus Macaque () Animal Model for Aerosolized Venezuelan Equine Encephalitis: Importance of Challenge Dose and Viral Subtype.定义用于气溶胶接种委内瑞拉马脑炎的食蟹猴()动物模型:挑战剂量和病毒亚型的重要性。
Viruses. 2023 Nov 29;15(12):2351. doi: 10.3390/v15122351.
5
Antibody Phage Display Technology for Sensor-Based Virus Detection: Current Status and Future Prospects.基于抗体噬菌体展示技术的传感器病毒检测:现状与未来展望。
Biosensors (Basel). 2023 Jun 9;13(6):640. doi: 10.3390/bios13060640.
6
Antibodies against Anthrax Toxins: A Long Way from Benchlab to the Bedside.抗炭疽毒素抗体:从实验室到床边的漫长道路。
Toxins (Basel). 2022 Feb 25;14(3):172. doi: 10.3390/toxins14030172.
7
Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.在使用黄病毒交叉反应性单克隆抗体治疗之前,暴露委内瑞拉马脑炎病毒 E1 糖蛋白上的隐匿表位,可在感染早期阻止病毒复制。
Virology. 2022 Jan 2;565:13-21. doi: 10.1016/j.virol.2021.09.007. Epub 2021 Sep 28.
8
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.通过噬菌体展示技术开发用于诊断和治疗的针对传染病和毒素的重组抗体。
Front Cell Infect Microbiol. 2021 Jul 7;11:697876. doi: 10.3389/fcimb.2021.697876. eCollection 2021.
9
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface.SARS-CoV-2 中和性人源重组抗体,来源于大流行前健康供体,结合 RBD-ACE2 界面。
Nat Commun. 2021 Mar 11;12(1):1577. doi: 10.1038/s41467-021-21609-2.
10
MOrPH-PhD: An Integrated Phage Display Platform for the Discovery of Functional Genetically Encoded Peptide Macrocycles.MOrPH-PhD:用于发现功能性基因编码肽大环化合物的集成噬菌体展示平台。
ACS Cent Sci. 2020 Mar 25;6(3):368-381. doi: 10.1021/acscentsci.9b00927. Epub 2020 Feb 4.
在致死性委内瑞拉马脑炎病毒气溶胶攻击后 24 小时用人类单克隆抗体治疗小鼠可预防疾病但不能预防感染。
Virology. 2011 Jun 5;414(2):146-52. doi: 10.1016/j.virol.2011.03.016. Epub 2011 Apr 13.
4
A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus.一种具有广泛血清型特异性的人源化鼠单克隆抗体可保护小鼠免受委内瑞拉马脑炎病毒的攻击。
Antiviral Res. 2011 Apr;90(1):1-8. doi: 10.1016/j.antiviral.2011.01.010. Epub 2011 Feb 15.
5
Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection.针对 E3 糖蛋白的抗体可保护小鼠免受致命委内瑞拉马脑炎病毒感染。
J Virol. 2010 Dec;84(24):12683-90. doi: 10.1128/JVI.01345-10. Epub 2010 Oct 6.
6
A human scFv antibody generation pipeline for proteome research.用于蛋白质组研究的人 scFv 抗体生成流水线。
J Biotechnol. 2011 Apr 10;152(4):159-70. doi: 10.1016/j.jbiotec.2010.09.945. Epub 2010 Sep 29.
7
Construction of human antibody gene libraries and selection of antibodies by phage display.人抗体基因文库的构建及通过噬菌体展示进行抗体筛选。
Methods Mol Biol. 2010;651:177-209. doi: 10.1007/978-1-60761-786-0_11.
8
Microbead electrochemiluminescence immunoassay for detection and identification of Venezuelan equine encephalitis virus.微球电化学发光免疫分析检测和鉴定委内瑞拉马脑炎病毒。
J Virol Methods. 2010 Nov;169(2):274-81. doi: 10.1016/j.jviromet.2010.07.022. Epub 2010 Aug 1.
9
The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.首张甲病毒 E1 和 E2 蛋白的人源表位图谱揭示了具有显著病毒中和活性的新 E2 表位。
PLoS Negl Trop Dis. 2010 Jul 13;4(7):e739. doi: 10.1371/journal.pntd.0000739.
10
A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus.一种重组人源化单克隆抗体可完全保护小鼠免受委内瑞拉马脑炎病毒的致死性攻击。
Vaccine. 2010 Aug 2;28(34):5558-64. doi: 10.1016/j.vaccine.2010.06.038. Epub 2010 Jun 25.